MERRIMACK PHARMACEUTICALS INC Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Merrimack Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Merrimack Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $233K, a 32.4% increase year-over-year.
  • Merrimack Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $925K.
  • Merrimack Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $868K, a 362% increase from 2022.
  • Merrimack Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $188K, a 840% increase from 2021.
  • Merrimack Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was $20K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $868K +$680K +362% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $188K +$168K +840% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $20K +$161K Jan 1, 2021 Dec 31, 2021 10-K 2022-03-09
2020 -$141K +$240K +63% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 -$381K +$2.51M +86.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 -$2.89M +$19.8M +87.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$22.6M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.